Serotonin enhances neurogenesis biomarkers, hippocampal volumes, and cognitive functions in Alzheimer’s disease
2024

Serotonin's Role in Alzheimer's Disease

Sample size: 133 publication 10 minutes Evidence: moderate

Author Information

Author(s): Azargoonjahromi Ali

Primary Institution: Shiraz University of Medical Sciences, Shiraz, Iran

Hypothesis

This study aimed to investigate the influence of serotonin on brain structure and hippocampal volumes in relation to cognitive functions in Alzheimer's disease.

Conclusion

Increased serotonin levels are associated with improved cognitive function and increased brain volume.

Supporting Evidence

  • Serotonin levels positively correlated with total brain volume and hippocampal volumes.
  • Higher serotonin levels were linked to better cognitive function.
  • After adjustments, correlations with neurogenesis biomarkers were not statistically significant.

Takeaway

Higher serotonin levels can help the brain grow bigger and make people think better, especially in those with Alzheimer's disease.

Methodology

Data from 133 ADNI participants with AD included cognitive assessments, serotonin measurements, and neurotrophic factors quantified via multiplex proteomics.

Potential Biases

Potential biases due to demographic composition and non-normal distributions in variables.

Limitations

The cross-sectional design limits causal relationships, and the sample size may not represent the broader AD population.

Participant Demographics

79 males and 54 females, ages ranged from 56 to 90 years, mean age 76.20 years.

Statistical Information

P-Value

p=0.023

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/s13041-024-01169-4

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication